Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
EZZ Life Science Holdings Community
ASX:EZZ Community
1
Narratives
written by author
0
Comments
on narratives written by author
19
Fair Values set
on narratives written by author
Create a narrative
EZZ Life Science Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
EZZ Life Science Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US Rebranding And New Product Launches Will Broaden Global Reach
Key Takeaways Expansion into the US and new product launches are set to drive significant revenue growth and enhance market share. Improved operational efficiency and new distribution channels indicate increased profitability and promising future financial performance.
View narrative
AU$5.15
FV
70.3% undervalued
intrinsic discount
16.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
EZZ
EZZ
EZZ Life Science Holdings
Your Fair Value
AU$
Current Price
AU$1.53
2.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
150m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$150.1m
Earnings AU$18.0m
Advanced
Set Fair Value